Functional impact of white matter hyperintensities in cognitively normal elderly subjects.
OBJECTIVE
To investigate the impact white matter hyperintensities (WMH) detected on magnetic resonance imaging have on motor dysfunction and cognitive impairment in elderly subjects without dementia.


METHODS
Cross-sectional study.


METHODS
Population-based study on the incidence and prevalence of cognitive impairment in Olmsted County, Minnesota.


METHODS
A total of 148 elderly subjects (65 men) without dementia ranging in age from 73 to 91 years.


METHODS
We measured the percentage of the total white matter volume classified as WMH in a priori-defined brain regions (ie, frontal, temporal, parietal, occipital, periventricular, or subcortical). Motor impairment was evaluated qualitatively using the Unified Parkinson's Disease Rating Scale summary measures of motor skills and quantitatively using a digitized portable walkway system. Four cognitive domains were evaluated using z scores of memory, language, executive function, and visuospatial reasoning.


RESULTS
A higher WMH proportion in all regions except the occipital lobe was associated with lower executive function z score (P value <.01). A higher WMH proportion in all regions, but most strongly for the parietal lobe, correlated with higher Unified Parkinson's Disease Rating Scale gait, posture, and postural stability sum (P value <.01). A higher WMH proportion, whether periventricular, subcortical, or lobar, correlated with reduced velocity (P value <.001).


CONCLUSIONS
We conclude that executive function is the primary cognitive domain affected by WMH burden. The data suggest that WMH in the parietal lobe are chiefly responsible for reduced balance and postural support compared with the other 3 lobes and may alter integration of sensory information via parietal lobe dysfunction in the aging brain. Parietal white matter changes were not the predominant correlate with motor speed, lending evidence to a global involvement of neural networks in gait velocity.
Department of Neuroscience (Neuropathology), Mayo Clinic, Jacksonville, Florida, USA.
Melissa E
ME
Murray
Matthew L
ML
Senjem
Ronald C
RC
Petersen
John H
JH
Hollman
Greg M
GM
Preboske
Stephen D
SD
Weigand
David S
DS
Knopman
Tanis J
TJ
Ferman
Dennis W
DW
Dickson
Clifford R
CR
Jack
D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000473:pathology* / Q000502:physiology; D001931:Brain Mapping; D003071:Cognition / Q000502:physiology*; D003072:Cognition Disorders / Q000209:etiology* / Q000473:pathology; D003430:Cross-Sectional Studies; D056344:Executive Function / Q000502:physiology*; D005260:Female; D005684:Gait; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008568:Memory / Q000502:physiology*; D009413:Nerve Fibers, Myelinated / Q000473:pathology* / Q000502:physiology; D009483:Neuropsychological Tests; D012044:Regression Analysis